Home > Insider Trading > Filing (0001193805-14-000059)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438533	Retrophin Inc.	RTRX	Pharmaceutical Preparations (2834)	262383102

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1525354	Martin Shkreli	C/O Retrophin, Inc. 777 Third Avenue, 22Nd Floor New York NY 10017	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-12	5,556	$4.50	2,665,596	No	4	P	Direct
Common Stock	Acquisiton	2013-09-12	2,904	$0.00	2,668,500	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	J	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Purchase Warrants	Acquisiton	2013-09-12	2,778	$0.00	2,778	$6.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,778	2013-09-12	2018-08-15	No	4	P	Direct

Footnotes

On September 12, 2013, in connection with a private placement of the Issuer's securities, the Reporting Person acquired 5,556 shares of the Issuer's common stock, par value $0.0001 per share, at a purchase price of $4.50 per share, and Common Stock Purchase Warrants to purchase up to an aggregate of 2,778 shares of common stock, and received an additional 2,904 shares in connection with the waiver of certain rights under a registration rights agreement. The aggregate purchase price paid by the Reporting Person in the transaction was $25,000.
This Amendment No. 1 to the Form 4 filed with the Commission on September 16, 2013 is being filed solely to reflect the final number of shares and warrants received by the Reporting Person in connection with such private placement transaction.